Matasar, M., Bartlett, N. L., Sehn, L. H., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., Ku, M., Nastoupil, L. J., Wei, M. C., Yin, S., To, I., Turner, D., Huang, H., Min, J., Penuel, E., & Budde, L. E. (n.d.). p1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY. HemaSphere, 6, 1016–1017. http://access.bl.uk/ark:/81055/vdc_100159756296.0x000010